Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Exploring Risk Assessment and Recovery From COVID-19 Infection in Hospitalised Patients in Hong Kong
Total 0 results
Nothing found
Sponsors and Collaborators
Saint Pierre Institute - Palavas les Flots
Invicta Medical Inc.
YASEMİN AYDIN KARTAL
Sichuan Haisco Pharmaceutical Group Co., Ltd
Phramongkutklao College of Medicine and Hospital
Eastman Kodak Company
Aga Khan Foundation, Pakistan
Yancheng City NO.1 People's Hospital
Grünenthal Denmark ApS
Doterra Healing Hands Foundation
CeRSM
Gregorio Covino
Erzurum Regional Training & Research Hospital
Outpatient Endovascular and Interventional Society
CARITAS Rundum zu Hause betreut
Department of Anesthesiology, North Denmark Regional Hospital
EMET Pharmaceuticals, LLC
Alessandra Palo
Axon Neuroscience SE
Irish Endocrine Society
View Full List
Medical Conditions
Ferritin Threshold
Pelvic and Groin Areas Biopsy
Central Motor Disorders
Reading Disability
HIV Pre-exposure Prophylaxis Use
Modality of Discharge Instructions
Skeletal Muscle Energy Metabolism
Bioequivalence, AUC, Cmax, Pharmacokinetics
Hypogonadism, Hypogonadotropic
Acute Endophthalmitis Post-operative
Hemopathies
Human Risk Factors
Chondrosis
Venous Puncture
Abdominal Compartment Syndrome
Osteopathic Manipulative Treatment
Major Depressive Disorder, Recurrent Episode, Severe
Neutrophilia Acute
Pharmacokinetics of Plasma Phenolic Glucuronide of MPA (MPAG)
Mineralocorticoid Excess
View Full List
Drug Interventions
MYL-1501D product using manufacture process VI
Pacritinib
Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen
Naltrexone 50 Mg + Inactive Marijuana (0% THC)
Systemic intravenous lidocaine infusion
Betamethasone
Carbetocin
Enteral oxygen therapy
Apatinib
Amantadine Sulfate
Risperidone
Anti-PD1 antibody, nimotuzumab and capecitabine
Neridronate
Lenalidomide
Niraparib
Test varnish
Pregabalin
LY2216684
Leuprolide acetate 11.25 mg
Ranitidine
View Full List
CROs by country
Contract Research Organizations in Algeria
Contract Research Organizations in Belgium
Contract Research Organizations in Burkina Faso
Contract Research Organizations in Ecuador
Contract Research Organizations in Indonesia
Contract Research Organizations in Japan
Contract Research Organizations in Latvia
Contract Research Organizations in Pakistan
Contract Research Organizations in Panama
Contract Research Organizations in Portugal
Contract Research Organizations in Trinidad & Tobago
Contract Research Organizations in Turkmenistan
Contract Research Organizations in Uruguay
CRO list by country
CROs in Ireland
Atlantia Clinical Trials
Parexel
Aixial
SGS
ICON
Pivotal
Venn Life Sciences
Charles River Laboratories
IQVIA
MAC Clinical Research®
All CROs in Ireland
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe